Quantinno Capital Management Portfolio holdings
Quantinno Capital Management is an investment adviser that builds personalized long/short stock portfolios designed to cut the taxes its clients pay, using tax-loss harvesting. Its models pick the positions, and its strategies include moving investors out of a concentrated holding into a diversified portfolio in a tax-efficient way. Quantinno began advising in 2018 and is principally owned by Hoon Kim. Qualified individuals commonly reach its managed accounts through financial advisers who have engaged it to manage money for their clients.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.09B |
| 2 |
Apple
AAPL
|
+$921M |
| 3 |
Microsoft
MSFT
|
+$674M |
| 4 |
Amazon
AMZN
|
+$425M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$342M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$104M |
| 2 |
Janus Henderson
JHG
|
+$88M |
| 3 |
Leggett & Platt
LEG
|
+$74M |
| 4 |
Electronic Arts
EA
|
+$69.1M |
| 5 |
TJX Companies
TJX
|
+$58.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.8% |
| 2 | Financials | 12.24% |
| 3 | Industrials | 10.01% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Healthcare | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3551
Crawford & Co Class A
CRD.A
$568M
| $134K | ﹤0.01% |
10,737
-423
| -4% | -$5.18K |
2025 Q4
3 quarters
|
|
3552
Aclaris Therapeutics
ACRS
$622M
| $133K | ﹤0.01% |
+25,193
| New | +$144K |
2026 Q3
0 quarters
|
|
3553
Nomad Foods
NOMD
$1.67B
| $127K | ﹤0.01% |
+12,338
| New | +$142K |
2026 Q3
0 quarters
|
|
3554
Precision BioSciences
DTIL
$289M
| $126K | ﹤0.01% |
20,124
| – | – |
2026 Q1
2 quarters
|
|
3555
NioCorp Developments
NB
$406M
| $126K | ﹤0.01% |
34,986
-138,624
| -80% | -$598K |
2026 Q1
2 quarters
|
|
3556
Angel Oak Mortgage-Backed Securities ETF
MBS
$190M
| $126K | ﹤0.01% |
15,403
+1,265
| +9% | +$10.8K |
2026 Q1
2 quarters
|
|
3557
Nextdoor Holdings, Inc. Class A Common Stock
NXDR
$789M
| $124K | ﹤0.01% |
50,946
+31,023
| +156% | +$73.9K |
2025 Q4
3 quarters
|
|
3558
Algonquin Power & Utilities
AQN
$4.31B
| $121K | ﹤0.01% |
24,103
+154
| +0.6% | +$867 |
2025 Q4
3 quarters
|
|
3559
Eaton Vance Limited Duration Income Fund
EVV
$976M
| $112K | ﹤0.01% |
13,244
-2,546
| -16% | -$23K |
2026 Q2
1 quarter
|
|
3560
Petco
WOOF
$816M
| $110K | ﹤0.01% |
48,260
+13,166
| +38% | +$34.5K |
2024 Q4
7 quarters
|
|
3561
Evolent Health
EVH
$554M
| $109K | ﹤0.01% |
31,262
-69,634
| -69% | -$309K |
2026 Q2
1 quarter
|
|
3562
Precigen
PGEN
$1.63B
| $107K | ﹤0.01% |
+12,480
| New | +$81.9K |
2026 Q3
0 quarters
|
|
3563
Nuveen Preferred & Income Opportunities Fund
JPC
$2.56B
| $106K | ﹤0.01% |
15,474
-246
| -2% | -$1.84K |
2025 Q2
5 quarters
|
|
3564
Nuveen Quality Municipal Income Fund
NAD
$2.44B
| $105K | ﹤0.01% |
10,371
| – | – |
2026 Q1
2 quarters
|
|
3565
MannKind Corp
MNKD
$1.33B
| $101K | ﹤0.01% |
+26,015
| New | +$102K |
2026 Q3
0 quarters
|
|
3566
OmniAb
OABI
$716M
| $98.5K | ﹤0.01% |
+19,855
| New | +$67.8K |
2026 Q3
0 quarters
|
|
3567
Akebia Therapeutics
AKBA
$132M
| $96.2K | ﹤0.01% |
104,536
-457,587
| -81% | -$492K |
2026 Q2
1 quarter
|
|
3568
N-able
NABL
$861M
| $92.1K | ﹤0.01% |
22,475
+8,125
| +57% | +$33.4K |
2025 Q1
6 quarters
|
|
3569
Enovix
ENVX
$351M
| $91.7K | ﹤0.01% |
39,525
-147,993
| -79% | -$464K |
2025 Q1
6 quarters
|
|
3570
Invivyd
IVVD
$172M
| $85.9K | ﹤0.01% |
98,688
+81,784
| +484% | +$64.8K |
2026 Q2
1 quarter
|
|
3571
Inter&Co
INTR
$1.83B
| $80.3K | ﹤0.01% |
15,030
-1,684
| -10% | -$9.23K |
2025 Q1
6 quarters
|
|
3572
indie Semiconductor
INDI
$512M
| $79.4K | ﹤0.01% |
27,162
+5,310
| +24% | +$19.6K |
2026 Q2
1 quarter
|
|
3573
GoodRx Holdings
GDRX
$1.21B
| $79.4K | ﹤0.01% |
+24,135
| New | +$80.4K |
2026 Q3
0 quarters
|
|
3574
Taysha Gene Therapies
TSHA
$1.34B
| $76.6K | ﹤0.01% |
+15,730
| New | +$90.7K |
2026 Q3
0 quarters
|
|
3575
Coty
COTY
$3.56B
| $76.5K | ﹤0.01% |
+29,313
| New | +$77.7K |
2026 Q3
0 quarters
|
|
Similar funds
Quantinno Capital Management's Q3 2026 Portfolio in Review
As of Q3 2026, Quantinno Capital Management held 3,703 positions worth $106B, up 27% from $83.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Quantinno Capital Management deployed $22.1B of net new capital in Q3 2026, opening 269 new positions and adding to 2,806 existing holdings. Its largest new stake was SK Hynix Inc: 390,668 shares worth $71.9M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was 10x Genomics, an estimated $104M trimmed.
- Quantinno Capital Management's largest Q3 2026 buy was SK Hynix Inc: 390,668 shares worth $71.9M.
- Quantinno Capital Management added most to NVIDIA in Q3 2026, an estimated $1.09B increase.
- Quantinno Capital Management's biggest Q3 2026 reduction was 10x Genomics, cutting an estimated $104M.
- Quantinno Capital Management fully exited Janus Henderson in Q3 2026, selling an estimated $88M.
- Quantinno Capital Management's ten largest holdings make up 24% of its $106B portfolio in Q3 2026.
- Quantinno Capital Management opened 269 new positions and closed 84 in Q3 2026.
- Quantinno Capital Management's portfolio value rose 27% quarter-over-quarter to $106B.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.